| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/14/2010 | CA2373266C Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 09/14/2010 | CA2370393C Dna sequence, and recombinant production of a gramineae allergen |
| 09/14/2010 | CA2343569C Mammalian transforming growth factor beta - 9 |
| 09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
| 09/14/2010 | CA2261345C Feline polynucleotide vaccine formula |
| 09/14/2010 | CA2260291C Antagonists of intestinotrophic glp-2 peptides |
| 09/14/2010 | CA2257821C Genes from 20q13 amplicon and their uses |
| 09/14/2010 | CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth |
| 09/14/2010 | CA2195970C Production of collagen in the milk of transgenic mammals |
| 09/14/2010 | CA2166406C Recombinant swinepox virus |
| 09/14/2010 | CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| 09/10/2010 | WO2010102297A2 Protein-containing foams, manufacture and use thereof |
| 09/10/2010 | WO2010102262A1 Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof |
| 09/10/2010 | WO2010102172A1 Methods and compositions for controlling plant pests |
| 09/10/2010 | WO2010102133A1 Artificial oxygen transport protein |
| 09/10/2010 | WO2010102052A2 Methods of inhibiting photoreceptor apoptosis |
| 09/10/2010 | WO2010101870A1 Compositions and methods for generating interleukin-35-induced regulatory t cells |
| 09/10/2010 | WO2010101793A2 Methods and compositions for the diagnosis, prognosis and treatment of cancer |
| 09/10/2010 | WO2010101628A2 Methods and products for in vivo enzyme profiling |
| 09/10/2010 | WO2010101526A1 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof |
| 09/10/2010 | WO2010101248A1 Cell proliferation inhibitor and method for screening same |
| 09/10/2010 | WO2010101237A1 Polypeptides and antibacterial or antiseptic use of same |
| 09/10/2010 | WO2010101192A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
| 09/10/2010 | WO2010101158A1 Novel gene derived from clostridium cellulovorans and use thereof |
| 09/10/2010 | WO2010101129A1 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors |
| 09/10/2010 | WO2010100878A1 Vangl1 peptides and vaccines including the same |
| 09/10/2010 | WO2010100646A1 Peptides derived from ficolin as surfactants |
| 09/10/2010 | WO2010100396A1 Modified omci as a complement inhibitor |
| 09/10/2010 | WO2010100351A1 Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia |
| 09/10/2010 | WO2010100150A1 Method for increasing the pool of ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass |
| 09/10/2010 | WO2010099960A2 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 09/10/2010 | WO2010099956A1 Cloning and recombinant production of vespula venom protease and methods of use thereof |
| 09/10/2010 | WO2010099746A1 Glucagon-like peptide-2 analogues, preparation method and use thereof |
| 09/10/2010 | WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein |
| 09/10/2010 | WO2010079314A3 Polypeptides and use thereof |
| 09/10/2010 | WO2010075960A3 Method for producing riboflavin |
| 09/10/2010 | WO2010073009A3 Peptide inhibitors of aquaporin-4 and their use |
| 09/10/2010 | WO2010053877A3 Mhc ii associated protein and uses thereof |
| 09/10/2010 | WO2010036948A3 Dna vaccine against influenza virus and prime boost method |
| 09/10/2010 | WO2010030140A3 A prokaryotic expansin protein for activating cellulose expansion and cellulose-degrading composition comprising the same |
| 09/10/2010 | WO2010008823A3 Purification of modified cytokines |
| 09/10/2010 | WO2009003074A3 Cholinergic/serotoninergic chimeric receptor and uses thereof |
| 09/10/2010 | CA2754476A1 Stabilized reverse transcriptase fusion proteins |
| 09/10/2010 | CA2754461A1 Temperature sensitive mutants of matrix metalloprotease 1 and uses thereof |
| 09/10/2010 | CA2754335A1 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3 |
| 09/10/2010 | CA2754065A1 Methods of inhibiting photoreceptor apoptosis |
| 09/10/2010 | CA2753918A1 Methods and compositions for controlling plant pests |
| 09/10/2010 | CA2753896A1 Protein-containing foams, manufacture and use thereof |
| 09/10/2010 | CA2753681A1 Vangl1 peptides and vaccines including the same |
| 09/10/2010 | CA2753621A1 Antibodies and epitopes specific to misfolded prion protein |
| 09/10/2010 | CA2753616A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
| 09/09/2010 | US20100228007 Mhc-peptide complex binding ligands |
| 09/09/2010 | US20100227820 Effect of Porcine Sheath Proteins on the Regeneration Activity of Periodontal Ligament |
| 09/09/2010 | US20100227815 Site-specific pegylated linear salmon calcitonin analogues |
| 09/09/2010 | US20100227808 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 09/09/2010 | US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases |
| 09/09/2010 | US20100227803 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/09/2010 | US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides |
| 09/09/2010 | US20100227796 Insulin Derivatives |
| 09/09/2010 | US20100227777 Isolating biological modulators from biodiverse gene fragment libraries |
| 09/09/2010 | US20100227407 Aav4 vector and uses thereof |
| 09/09/2010 | US20100227403 rbLIF PROTEIN FOR USE IN EMBRYONIC STEM CELL CULTURES |
| 09/09/2010 | US20100227400 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 09/09/2010 | US20100227392 Use of RPA32, RPA4, and RPA4/RPA32 Hybrid Polypeptides and Polynucleotides for Assessing and Modulating Cell Proliferation |
| 09/09/2010 | US20100227362 Novel YLMPO1 Gene Derived From Yarrowia Lipolytica and A Process for Preparing a Glycoprotein Not Being Mannosylphosphorylated By Using a Mutated Yarrowia Lipolytica in Which YLMPO1 Gene is Disrupted |
| 09/09/2010 | US20100227354 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/09/2010 | US20100227343 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/09/2010 | US20100227335 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/09/2010 | US20100227333 Method of detecting infection with urogenital mycoplasmas in humans and a kit for diagnosing same |
| 09/09/2010 | US20100226987 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226961 Cross-linked bioactive hydrogel matrices |
| 09/09/2010 | US20100226957 Protein-Based Artificial Retinas |
| 09/09/2010 | US20100226951 Methods and compositions for controlling plant pests |
| 09/09/2010 | US20100226934 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 09/09/2010 | US20100226933 Hypoallergenic proteins |
| 09/09/2010 | US20100226924 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226915 AGER-Peptides and Use Thereof |
| 09/09/2010 | US20100226911 Treating or preventing extracellular matrix build-up |
| 09/09/2010 | US20100226891 Surface expression vector for fusion protein of myo-2 peptide multimer and myostatin, and microorganism transformed by thereof |
| 09/09/2010 | US20100226856 Dynamic bio-nanoparticle elements |
| 09/09/2010 | US20100226854 MHC Peptide Complexes and Uses Thereof in Infectious Diseases |
| 09/08/2010 | EP2226385A1 Human Coagulation Factor VII Variants |
| 09/08/2010 | EP2226334A2 Immunoregulatory structures from normally occuring proteins |
| 09/08/2010 | EP2226332A1 Mycobacterium tuberculosis epitopes and methods of use thereof |
| 09/08/2010 | EP2226085A1 Anti-angiogenic compositions and methods of use |
| 09/08/2010 | EP2226081A1 Peptide vaccine using mimic molecule of amyloid beta-peptide |
| 09/08/2010 | EP2225380A2 Lipid metabolism protein and uses thereof i (bzip transcription factor) |
| 09/08/2010 | EP2225379A2 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 09/08/2010 | EP2225378A2 Plants having increased yield-related traits and a method for making the same |
| 09/08/2010 | EP2225375A1 Improvement of the secretion yield of a protein of interest by in vivo proteolytic processing of a multimeric precursor |
| 09/08/2010 | EP2225272A2 Novel peptides derived from ncam (fgls) |
| 09/08/2010 | EP2225271A2 New non-selective somatostatin analogues |
| 09/08/2010 | EP2225270A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 09/08/2010 | EP2225269A2 Fusion proteins of mannose binding lectins for treatment of disease |
| 09/08/2010 | EP2225268A1 Immunoassays and kits for the detection of ngal |
| 09/08/2010 | EP2225267A1 Polypeptides comprising an ice-binding activity |
| 09/08/2010 | EP2225266A1 Novel wheat allergens |
| 09/08/2010 | EP2225265A2 Streptococcus pneumoniae vaccines |